1. Editorial

   • Henning T. Mouridsen

   Editorial Open access 03 October 2007 Pages: 1 - 2

2. The early days of letrozole

   • Ajay S. Bhatnagar

   Review Open access 03 October 2007 Pages: 3 - 5

3. The discovery and mechanism of action of letrozole

   • Ajay S. Bhatnagar

   Review Open access 03 October 2007 Pages: 7 - 17

   

4. Letrozole in advanced breast cancer: the PO25 trial

   • Henning T. Mouridsen

   Review Open access 27 February 2007 Pages: 19 - 29

   

5. Letrozole in advanced breast cancer: the PO25 trial

   • Henning T. Mouridsen

   Erratum Open access 08 May 2007 Pages: 31 - 31

6. Letrozole in the neoadjuvant setting: the P024 trial

   • Matthew J. Ellis
   • Cynthia Ma

   Review Open access 03 October 2007 Pages: 33 - 43

   

7. Letrozole in the extended adjuvant setting: MA.17

   • Paul E. Goss

   Review Open access 03 October 2007 Pages: 45 - 53

   

8. Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98

   • Dieter Koeberle
   • Beat Thuerlimann

   Review Open access 03 October 2007 Pages: 55 - 66

   

9. A decade of letrozole: FACE

   • Joyce O’Shaughnessy

   Review Open access 03 October 2007 Pages: 67 - 74

   

10. Safety of aromatase inhibitors in the adjuvant setting

    • Edith A. Perez

    Review Open access 03 October 2007 Pages: 75 - 89

    

11. The patient experience

    • Nadia Harbeck
    • Renate Haidinger

    Review Open access 03 October 2007 Pages: 91 - 103

12. Femara^® and the future: tailoring treatment and combination therapies with Femara

    • Matthew Ellis
    • Cynthia Ma

    Review Open access 03 October 2007 Pages: 105 - 115